CN104225295A - 用于改善睡眠的组合物及其制备方法和应用 - Google Patents
用于改善睡眠的组合物及其制备方法和应用 Download PDFInfo
- Publication number
- CN104225295A CN104225295A CN201410418374.5A CN201410418374A CN104225295A CN 104225295 A CN104225295 A CN 104225295A CN 201410418374 A CN201410418374 A CN 201410418374A CN 104225295 A CN104225295 A CN 104225295A
- Authority
- CN
- China
- Prior art keywords
- extractum
- compositions
- cordyceps militaris
- link
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 68
- 238000002360 preparation method Methods 0.000 title claims abstract description 20
- 230000007958 sleep Effects 0.000 title abstract description 39
- 241001264174 Cordyceps militaris Species 0.000 claims abstract description 59
- 241000005787 Cistanche Species 0.000 claims abstract description 43
- 239000000284 extract Substances 0.000 claims abstract description 43
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 41
- 239000003814 drug Substances 0.000 claims abstract description 30
- 239000002994 raw material Substances 0.000 claims abstract description 27
- 238000010992 reflux Methods 0.000 claims abstract description 13
- 238000000605 extraction Methods 0.000 claims abstract description 8
- 238000000108 ultra-filtration Methods 0.000 claims abstract description 7
- 238000002156 mixing Methods 0.000 claims abstract description 3
- 239000000706 filtrate Substances 0.000 claims description 44
- 210000000582 semen Anatomy 0.000 claims description 25
- 239000000243 solution Substances 0.000 claims description 22
- 239000004615 ingredient Substances 0.000 claims description 14
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 10
- 239000008187 granular material Substances 0.000 claims description 10
- 102000057297 Pepsin A Human genes 0.000 claims description 9
- 108090000284 Pepsin A Proteins 0.000 claims description 9
- 102000004190 Enzymes Human genes 0.000 claims description 7
- 108090000790 Enzymes Proteins 0.000 claims description 7
- 102000004142 Trypsin Human genes 0.000 claims description 7
- 108090000631 Trypsin Proteins 0.000 claims description 7
- 229940088598 enzyme Drugs 0.000 claims description 7
- 239000012588 trypsin Substances 0.000 claims description 7
- 230000001476 alcoholic effect Effects 0.000 claims description 6
- 229940111202 pepsin Drugs 0.000 claims description 6
- 238000001291 vacuum drying Methods 0.000 claims description 6
- 235000013402 health food Nutrition 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 5
- 239000012141 concentrate Substances 0.000 claims description 4
- 230000009849 deactivation Effects 0.000 claims description 4
- 230000006872 improvement Effects 0.000 claims description 4
- 239000006187 pill Substances 0.000 claims description 4
- 230000003750 conditioning effect Effects 0.000 claims description 3
- 239000007902 hard capsule Substances 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 3
- 239000002552 dosage form Substances 0.000 claims description 2
- 239000006196 drop Substances 0.000 claims description 2
- 239000012467 final product Substances 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims description 2
- 238000012423 maintenance Methods 0.000 claims description 2
- 239000007901 soft capsule Substances 0.000 claims description 2
- 239000000463 material Substances 0.000 abstract description 32
- 230000000694 effects Effects 0.000 abstract description 30
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 16
- 229940079593 drug Drugs 0.000 abstract description 15
- 235000013305 food Nutrition 0.000 abstract description 7
- 239000004480 active ingredient Substances 0.000 abstract description 4
- 231100000331 toxic Toxicity 0.000 abstract description 4
- 230000002588 toxic effect Effects 0.000 abstract description 4
- 238000005516 engineering process Methods 0.000 abstract description 3
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 2
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 2
- 244000274050 Platycodon grandiflorum Species 0.000 abstract 2
- 235000006753 Platycodon grandiflorum Nutrition 0.000 abstract 2
- 241000209140 Triticum Species 0.000 abstract 2
- 235000021307 Triticum Nutrition 0.000 abstract 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 2
- 235000011477 liquorice Nutrition 0.000 abstract 2
- 235000006545 Ziziphus mauritiana Nutrition 0.000 abstract 1
- 244000126002 Ziziphus vulgaris Species 0.000 abstract 1
- 235000008529 Ziziphus vulgaris Nutrition 0.000 abstract 1
- 239000002131 composite material Substances 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 description 22
- QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 19
- 229960002275 pentobarbital sodium Drugs 0.000 description 19
- 241000699666 Mus <mouse, genus> Species 0.000 description 17
- 238000002474 experimental method Methods 0.000 description 13
- 241000699670 Mus sp. Species 0.000 description 11
- 230000037396 body weight Effects 0.000 description 11
- 238000010298 pulverizing process Methods 0.000 description 11
- 238000004140 cleaning Methods 0.000 description 10
- 210000003734 kidney Anatomy 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- 229960000796 barbital sodium Drugs 0.000 description 8
- FTOAOBMCPZCFFF-UHFFFAOYSA-N barbitone sodium Natural products CCC1(CC)C(=O)NC(=O)NC1=O FTOAOBMCPZCFFF-UHFFFAOYSA-N 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 8
- 238000003304 gavage Methods 0.000 description 8
- 230000001939 inductive effect Effects 0.000 description 8
- RGHFKWPGWBFQLN-UHFFFAOYSA-M sodium;5,5-diethylpyrimidin-3-ide-2,4,6-trione Chemical compound [Na+].CCC1(CC)C([O-])=NC(=O)NC1=O RGHFKWPGWBFQLN-UHFFFAOYSA-M 0.000 description 8
- 238000001914 filtration Methods 0.000 description 7
- 208000019116 sleep disease Diseases 0.000 description 7
- 208000020685 sleep-wake disease Diseases 0.000 description 7
- 230000002936 tranquilizing effect Effects 0.000 description 7
- 206010003084 Areflexia Diseases 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 6
- 238000002347 injection Methods 0.000 description 6
- 239000007924 injection Substances 0.000 description 6
- 210000004072 lung Anatomy 0.000 description 6
- 230000028527 righting reflex Effects 0.000 description 6
- 238000002791 soaking Methods 0.000 description 6
- 210000000952 spleen Anatomy 0.000 description 6
- 241000721047 Danaus plexippus Species 0.000 description 5
- 230000000517 effect on sleep Effects 0.000 description 5
- 239000012567 medical material Substances 0.000 description 5
- 230000004620 sleep latency Effects 0.000 description 5
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 4
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 4
- 230000001914 calming effect Effects 0.000 description 4
- 150000004676 glycans Chemical class 0.000 description 4
- 230000000147 hypnotic effect Effects 0.000 description 4
- 206010022437 insomnia Diseases 0.000 description 4
- -1 phenethyl alcohol glycoside Chemical class 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 3
- 229920001353 Dextrin Polymers 0.000 description 3
- 239000004375 Dextrin Substances 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 239000002671 adjuvant Substances 0.000 description 3
- 230000004071 biological effect Effects 0.000 description 3
- 235000019425 dextrin Nutrition 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 229930182470 glycoside Natural products 0.000 description 3
- 235000008216 herbs Nutrition 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 230000010354 integration Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000003340 mental effect Effects 0.000 description 3
- 229920001184 polypeptide Polymers 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 230000003014 reinforcing effect Effects 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-Phenylethanol Natural products OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 2
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229960005305 adenosine Drugs 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 208000013116 chronic cough Diseases 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- WEXRUCMBJFQVBZ-UHFFFAOYSA-N pentobarbital Chemical compound CCCC(C)C1(CC)C(=O)NC(=O)NC1=O WEXRUCMBJFQVBZ-UHFFFAOYSA-N 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 230000004622 sleep time Effects 0.000 description 2
- 230000002557 soporific effect Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- JWZZKOKVBUJMES-UHFFFAOYSA-N (+-)-Isoprenaline Chemical compound CC(C)NCC(O)C1=CC=C(O)C(O)=C1 JWZZKOKVBUJMES-UHFFFAOYSA-N 0.000 description 1
- SVUOLADPCWQTTE-UHFFFAOYSA-N 1h-1,2-benzodiazepine Chemical compound N1N=CC=CC2=CC=CC=C12 SVUOLADPCWQTTE-UHFFFAOYSA-N 0.000 description 1
- NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 241000208671 Campanulaceae Species 0.000 description 1
- 241001480006 Clavicipitaceae Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 241000190633 Cordyceps Species 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010013980 Dyssomnias Diseases 0.000 description 1
- 241000221775 Hypocreales Species 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 241000207832 Lamiales Species 0.000 description 1
- 241000308150 Orobanchaceae Species 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 208000006199 Parasomnias Diseases 0.000 description 1
- CWRVKFFCRWGWCS-UHFFFAOYSA-N Pentrazole Chemical compound C1CCCCC2=NN=NN21 CWRVKFFCRWGWCS-UHFFFAOYSA-N 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 241000357613 Platycodon Species 0.000 description 1
- 235000006751 Platycodon Nutrition 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000000935 antidepressant agent Substances 0.000 description 1
- 229940005513 antidepressants Drugs 0.000 description 1
- 229940125717 barbiturate Drugs 0.000 description 1
- HNYOPLTXPVRDBG-UHFFFAOYSA-N barbituric acid Chemical compound O=C1CC(=O)NC(=O)N1 HNYOPLTXPVRDBG-UHFFFAOYSA-N 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 229940049706 benzodiazepine Drugs 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000005978 brain dysfunction Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229960001317 isoprenaline Drugs 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 150000003833 nucleoside derivatives Chemical class 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 229960005152 pentetrazol Drugs 0.000 description 1
- 229960001412 pentobarbital Drugs 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229930189914 platycodon Natural products 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000004799 sedative–hypnotic effect Effects 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 229940125725 tranquilizer Drugs 0.000 description 1
- 239000003204 tranquilizing agent Substances 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
组别 | 给药品种和剂量 |
对照组 | 生理盐水 |
甘麦大枣组 | 对比例1制得的组合物(0.51g/kg·bw) |
北冬虫夏草组 | 实施例1制得的浸膏一(0.51g/kg·bw) |
肉苁蓉组 | 对比例2制得的组合物(0.51g/kg·bw) |
样品低剂量组 | 实施例1制得的颗粒剂(0.085g/kg·bw) |
样品中剂量组 | 实施例1制得的颗粒剂(0.17g/kg·bw) |
样品高剂量组 | 实施例1制得的颗粒剂(0.51g/kg·bw) |
组别 | 动物数/只 | 睡眠时间/min | 入睡动物数/只 |
对照组 | 12 | 0±0 | 0 |
甘麦大枣组 | 12 | 0±0 | 0 |
北冬虫夏草组 | 12 | 0±0 | 0 |
肉苁蓉组 | 12 | 0±0 | 0 |
样品低剂量组 | 12 | 0±0 | 0 |
样品中剂量组 | 12 | 0±0 | 0 |
样品高剂量组 | 12 | 0±0 | 0 |
组别 | 动物数/只 | 睡眠时间/min |
对照组 | 12 | 15.36±3.39 |
甘麦大枣组 | 12 | 21.25±3.41* |
北冬虫夏草组 | 12 | 20.03±3.41 |
肉苁蓉组 | 12 | 17.57±3.82 |
样品低剂量组 | 12 | 22.06±2.85** |
样品中剂量组 | 12 | 29.63±3.85** |
样品高剂量组 | 12 | 32.73±4.26** |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410418374.5A CN104225295B (zh) | 2014-08-21 | 2014-08-21 | 用于改善睡眠的组合物及其制备方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410418374.5A CN104225295B (zh) | 2014-08-21 | 2014-08-21 | 用于改善睡眠的组合物及其制备方法和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104225295A true CN104225295A (zh) | 2014-12-24 |
CN104225295B CN104225295B (zh) | 2017-02-08 |
Family
ID=52214771
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410418374.5A Active CN104225295B (zh) | 2014-08-21 | 2014-08-21 | 用于改善睡眠的组合物及其制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104225295B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104543270A (zh) * | 2015-02-05 | 2015-04-29 | 郭景龙 | 一种松茸巧克力 |
CN108837037A (zh) * | 2018-04-18 | 2018-11-20 | 北华大学 | 一种具有增强免疫力功能的组合物及其制备方法 |
CN115645496A (zh) * | 2021-06-02 | 2023-01-31 | 山西振东五和医养堂股份有限公司 | 一种甘麦大枣汤的制备方法 |
-
2014
- 2014-08-21 CN CN201410418374.5A patent/CN104225295B/zh active Active
Non-Patent Citations (3)
Title |
---|
宗静: ""蛹虫草子实体活性多肽的提取分离方法及其部分生物活性的研究"", 《中国优秀硕士学位论文全文数据库》 * |
张志全等: ""失眠的中医药治疗进展"", 《江西中医学院学报》 * |
韩发: "《中国虫草的现代研发与应用》", 31 May 2009 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104543270A (zh) * | 2015-02-05 | 2015-04-29 | 郭景龙 | 一种松茸巧克力 |
CN108837037A (zh) * | 2018-04-18 | 2018-11-20 | 北华大学 | 一种具有增强免疫力功能的组合物及其制备方法 |
CN115645496A (zh) * | 2021-06-02 | 2023-01-31 | 山西振东五和医养堂股份有限公司 | 一种甘麦大枣汤的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN104225295B (zh) | 2017-02-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103719498B (zh) | 一种提高免疫力的黄精保健茶及其制备方法 | |
CN111956753B (zh) | 一种药食同源的中药组合物及其制备方法和应用 | |
CN102697047B (zh) | 一种枸杞口服液的制备方法 | |
CN106806853A (zh) | 一种缓解体力疲劳和/或提高缺氧耐受力的中药组合物、其制备方法和应用 | |
CN103155985B (zh) | 一种黄精营养粉及其制备方法 | |
CN106177053A (zh) | 一种包含青钱柳叶和陈皮的降血糖保健组合物 | |
CN104225295B (zh) | 用于改善睡眠的组合物及其制备方法和应用 | |
CN105708970A (zh) | 一种具有降血糖功能的保健食品 | |
CN106924388B (zh) | 一种治疗失眠的药物组合物及其制备方法、制剂与应用 | |
CN1471845A (zh) | 一种以灵芝、天麻为原料的保健食品及其制备方法 | |
CN104824293A (zh) | 一种采用食用植物作为成分制成的抗失眠代用茶的制备方法 | |
CN106266239A (zh) | 改善记忆的组合物及其制备方法和应用 | |
CN105920269A (zh) | 一种女性保健药酒 | |
CN105902827A (zh) | 提高人体免疫力的中药组合物及其制备方法 | |
CN104938727A (zh) | 一种抗失眠代用茶的制备方法 | |
CN104824292A (zh) | 一种采用食用植物作为成分制成的抗失眠代用茶 | |
CN115089661A (zh) | 辅助调节内分泌代谢并抗癌防癌的人参组合物的应用 | |
CN103768153B (zh) | 用于治疗家禽气囊炎的中药组合物及其制备方法 | |
CN106511915A (zh) | 一种复方中药组合物在抑制皮肤黑色素瘤肺转移药物中的应用 | |
CN106138785A (zh) | 一种治疗神经衰弱的中药组合物及其制备方法 | |
CN105727089A (zh) | 含艾叶的药物组合物用于制备治疗肠易激综合症药物中的用途 | |
CN104920742A (zh) | 一种抗失眠代用茶 | |
CN102949681B (zh) | 一种预防或治疗感冒的组合物及其制备方法 | |
CN104840737A (zh) | 具有补气润肺作用的中药组合物及其制备方法和应用 | |
CN108310212A (zh) | 一种用于延缓衰老的药物及其制备方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Yuan Guangxin Inventor after: Sun Jingbo Inventor after: Han Xiao Inventor after: Shao Xiaotong Inventor after: Song Dandan Inventor after: Zhu Jinming Inventor after: Du Peige Inventor after: An Liping Inventor after: Zhao Nanxi Inventor after: Li Hongyu Inventor after: Xu Guangyu Inventor after: Sheng Yu Inventor after: Wang Manli Inventor before: Yuan Guangxin Inventor before: Han Xiao Inventor before: Shao Xiaotong Inventor before: Song Dandan Inventor before: Du Peige Inventor before: An Liping Inventor before: Zhao Nanxi Inventor before: Li Hongyu Inventor before: Xu Guangyu Inventor before: Sheng Yu Inventor before: Wang Manli Inventor before: Sun Jingbo |
|
COR | Change of bibliographic data | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240102 Address after: 513, No. 4 Zhuji Road, Tianhe District, Guangzhou, Guangdong Province, 510000 Patentee after: Guangzhou Zhenlebao Biotechnology Co.,Ltd. Address before: 132013 no.3999 Binjiang East Road, Fengman District, Jilin City, Jilin Province Patentee before: BEIHUA University |